Drugs / MSP-2020
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07329621 | Jan 2026 → Jan 2027 expected | — | Otsuka Pharmaceutical Development & Commercialization, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSP-2020 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07329621 ↗ |
| Route | Oral | “Single Oral Doses” NCT07329621 ↗ |